#RXRX

Last 24h 📉 Bearish 📉1

Last 7 Days 📉 Bearish 📉1

Last 30 Days 📉 Bearish 📉1

Release 📈 Stocks

Inductive Wins OpenADMET Challenge, Outpacing NVIDIA and Recursion

November 6, 2026 (37 minutes ago)

Inductive topped the OpenADMET CYP Direct Inhibition Challenge, marking its fourth straight win in AI drug discovery benchmarks while besting industry peers…

RXRX NVDA

🌍 US Read More →

Analyst 📈 Stocks

Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target

September 24, 2026 (43 days ago)

Goldman Sachs initiates Tempus AI at Neutral, balancing strong diagnostic growth and a $42 million Recursion partnership extension against looming contract renewal…

TEM RXRX

🌍 AMERICAS Read More →

News 📈 Stocks

Teladoc and Recursion Pharmaceuticals Face Dim Outlooks Amid Growth Struggles

September 10, 2026 (57 days ago)

Investors should avoid Teladoc and Recursion Pharmaceuticals as both companies grapple with declining revenue, stiff competition, and unproven business models in a…

LLY NVO BMY

🌍 NORTH AMER Read More →